US Stock MarketDetailed Quotes

SILO Silo Pharma

Watchlist

1.490
+0.130+9.56%

Close Aug 16 16:00 ET

1.510
+0.020+1.34%

Post 19:59 ET

6.68MMarket Cap-1262P/E (TTM)

Silo Pharma Stock Forum

Trytosaveabit

Aug 14 13:44

Update

$Silo Pharma (SILO.US)$ Silo Pharma Announces Agreement With Sever Pharma Solutions To Scale-Up Production And Continue Testing Of SP-26 Dissolvable Ketamine-Based Implant Targeting Chronic Pain And Fibromyalgia

105241489

Aug 9 09:21

$Silo Pharma (SILO.US)$
Update
$Silo Pharma (SILO.US)$ Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules

105241489

Aug 9 09:18

$Silo Pharma (SILO.US)$ coming up up

Trytosaveabit

Aug 7 07:14

News

$Silo Pharma (SILO.US)$ Reuters· 1 min ago
Silo Pharma Announces Partnership With Global Cro for Central Nervous System Homing Peptide

Trytosaveabit

Jul 22 15:46

Update

$Silo Pharma (SILO.US)$ Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules

Stock Region

Jul 19 19:44

Biopharmaceutical Company Announces Master Plan With Medical Technology Provider

Silo Pharma and Resyca BV Enter Device and CMC Development Master Plan.
Silo Pharma, Inc. (Nasdaq: SILO), a developmental stage biopharmaceutical company, announced that it has entered into a Device and CMC Development Master Plan with Resyca BV, a medical technology provider. This collaboration is particularly focused on the advancement of Silo's lead candidate, SPC-15, an intranasal prophylactic treatment for post-...